These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11859)

  • 41. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of aplastic anemia.
    Loughran TP; Storb R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):559-75. PubMed ID: 2193014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
    Locatelli F; Bruno B; Zecca M; Van-Lint MT; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
    Blood; 2000 Sep; 96(5):1690-7. PubMed ID: 10961865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.
    Storb R; Thomas ED; Buckner CD; Clift RA; Deeg HJ; Fefer A; Goodell BW; Sale GE; Sanders JE; Singer J; Stewart P; Weiden PL
    Ann Intern Med; 1980 Jan; 92(1):30-6. PubMed ID: 6985782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
    Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
    Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
    Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
    Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marrow transplantation for paroxysmal nocturnal hemoglobinuria.
    Kawahara K; Witherspoon RP; Storb R
    Am J Hematol; 1992 Apr; 39(4):283-8. PubMed ID: 1553957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine.
    Takpradit C; Prockop SE; Kernan NA; Scaradavou A; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F
    J Pediatr Hematol Oncol; 2018 May; 40(4):e220-e224. PubMed ID: 29432302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow transplantation in 65 patients with severe aplastic anemia.
    Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
    Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.
    Giebel S; Wojnar J; Krawczyk-Kulis M; Markiewicz M; Wylezoł I; Seweryn M; Holowiecka-Goral A; Holowiecki J
    Ann Transplant; 2006; 11(2):23-7; discussion 32-43. PubMed ID: 17494286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
    Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
    Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
    Stucki A; Leisenring W; Sandmaier BM; Sanders J; Anasetti C; Storb R
    Blood; 1998 Oct; 92(8):2742-9. PubMed ID: 9763558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
    Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic transplantation using CD34
    Purev E; Tian X; Aue G; Pantin J; Vo P; Shalabi R; Reger RN; Cook L; Ramos C; Cho E; Worthy T; Khuu H; Stroncek D; Young NS; Childs RW
    Br J Haematol; 2017 Mar; 176(6):950-960. PubMed ID: 28169418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
    Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
    Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retransplantation of human bone marrow. Two immunosuppressive drug regimens.
    Kersey J; Roloff J; Hokeness S; Johnson FL; Nesbit M; Krivit W
    Transplantation; 1975 Jun; 19(6):475-8. PubMed ID: 237352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.